Drug-food interactions in internal medicine: What physicians should know?;Interactions médicaments-aliments en médecine interne : Quels messages pour le clinicien ?

Revue de Medecine Interne

Volumn 36, Issue 8, 2015, Pages 530-539

  Mouly, S ^a,b   Morgand, M ^b   Lopes, A ^b   Lloret Linares, C ^a,b   Bergmann, J F ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Cytochrome P450 3A4; Drug food interactions; Grapefruit juice; Herbal medicines; P glycoprotein

Indexed keywords

ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN; VITAMIN;

AGED; AGING; CANCER PATIENT; CLINICAL PRACTICE; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG DOSE; DRUG EFFICACY; DRUG TOXICITY; ENTERIC FEEDING; FOOD DRUG INTERACTION; FRUIT; FUNCTIONAL FOOD; GRAFT RECIPIENT; GRAPEFRUIT JUICE; HERBAL MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERICUM PERFORATUM; INTERNAL MEDICINE; INTERNIST; LIFE THREAT; PARENTERAL NUTRITION; PATIENT CARE; PHYSICIAN; PROFESSIONAL KNOWLEDGE; RISK ASSESSMENT; SHORT SURVEY; VEGETABLE; BEVERAGE; DIETARY SUPPLEMENT; INTESTINE; METABOLISM;

BEVERAGES; DIETARY SUPPLEMENTS; FOOD-DRUG INTERACTIONS; FRUIT; HUMANS; INTERNAL MEDICINE; INTESTINES; VEGETABLES; VITAMINS;

EID: 84937732028     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2014.12.010     Document Type: Short Survey

References (57)

1. Dresser G.K., Bailey D.G. A basic conceptual and practical overview of interactions with highly prescribed drugs. Can J Clin Pharmacol 2002, 9:191-198.
2. Goldberg R.M., Mabee J., Chan L., Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 1996, 14:447-450.
3. Shou M. Prediction of pharmacokinetics and drug-drug interactions from in vitro metabolism data. Curr Opin Drug Discov Devel 2005, 8:66-77.
4. Watkins P.B. Drug metabolism by cytochromes P450 in liver and small bowel. Gastrointest Pharmacol 1992, 21:511-525.
5. Kaminsky L.S., Fasco M.J. Small intestinal cytochromes P450. Crit Rev Toxicol 1991, 21:407-422.
6. Genser D. Food and drug interaction: consequences for the nutrition/health status. Ann Nutr Metab 2008, 52(Suppl 1):29-32.
7. Singh B.N., Malhotra B.K. Effects of food on the clinical pharmacokinetics of anticancer agents. Clin Pharmacokinet 2004, 43:1127-1156.
8. Lin M.Y., Lin S.J., Chan S.C., Lu Y.C. Impact of food and antiacids on the pharmacokinetics of anti-tuberculosis drugs: systematic review and meta-analysis. Int J Tuberc Lung Dis 2010, 14:806-818.
9. Butterweck V., Derendorf H., Gaus W., Nahrstedt A., Schulz A., Unger M. Pharmacokinetic herb-drug interactions: are preventive screenings necessary and appropriate?. Planta Med 2004, 70:784-791.
10. Chan L.-N. Drug-nutrient interaction in clinical nutrition. Curr opin Clin Nutr Metab Care 2002, 5:327-332.
11. Schmidt L.E., Dalhoff K. Food-drug interactions. Drugs 2002, 62:1481-1502.
12. Lourenço R. Enteral feeding: drug/nutrient interaction. Clin Nutr 2001, 20:187-193.
13. Won C.S., Oberlies N.H., Paine M.F. Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport. Pharmacol Ther 2012, 136:186-191.
14. Thummel K.E., Kunze K.L., Shen D.D. Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction. Adv Drug Deliv 1997, 27:99-127.
15. Hall S.D., Thummel K.E., Watkins P.B., Lown K.S., Benet L.Z., Paine M.F., et al. Molecular and physical mechanisms of first-pass extraction. Drug Metab Dispos 1999, 27:161-166.
16. Krishna D.R., Klotz U. Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet 1994, 26:144-160.
17. Mouly S., Paine M.F. P-glycoprotein increases from proximal to distal regions of human small intestine. Pharm Res 2003, 20:1595-1599.
18. Thiebaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastan I., Willingham M.C. Cellular localization of the multidrug resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A 1987, 84:7735-7738.
19. Zhang Y., Benet L.Z. The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein. Clin Pharmacokinet 2001, 40:159-168.
20. Watkins P.B. Barrier function of CYP3A4 and P-glycoprotein in the small bowel. Adv Drug Deliv Rev 1997, 27:161-170.
21. Wacher V.J., Wu C.Y., Benet L.Z. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 1995, 13:129-134.
22. Aszalos A. Role of ATP-binding cassette (ABC) transporters in ineteractions between natural products and drugs. Curr Drug Metab 2008, 9:1010-1018.
23. Rodriguez-Fragoso L., Martinez-Arismendi J.L., Orozco-Bustos D., Reyez-Esparza J., Torres E., Burchiel S.W. Potential risks resulting from fruit/vegetable-drug interactions: effects on drug-metabolizing enzymes and drug transporters. J Food Sci 2011, 76:R112-R124.
24. Bailey D.G., Arnold M.O., Spence J.D. Grapefruit juice-drug interactions. Br J Clin Pharmacol 1998, 46:101-110.
25. Kane G.C., Lipsky J.J. Drug-grapefruit juice interactions. Mayo Clin Proc 2000, 75:933-942.
26. Lohezic-Le Devehat F., Marigny K., Doucet M., Javaudin L. Jus de pamplemousse et médicaments : une association à surveiller ?. Thérapie 2002, 57:432-445.
27. Bailey D.G., Dresser G., Arnold M.O. Grapefruit-medication interactions: forbidden fruit or avoidable consequences?. CMAJ 2013, 185:309-316.
28. Paine M.F., Khalighi M., Fisher J.M., Shen D.D., Kunze K.L., Marsh C.L., et al. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J Pharmacol Exp Ther 1997, 283:1552-1562.
29. Greenblatt D.J., von Moltke L.L., Harmatz J.S., Chen G., Weemhoff J.L., Kelley C.J., et al. Time course of recovery of cytochrome P450 3A function after single dose of grapefruit juice. Clin Pharmacol Ther 2003, 74:121-129.
30. Lilja J.J., Kivisto K.T., Neuvonen P.J. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin. Clin Pharmacol Ther 2000, 68:384-390.
31. Dresser G.K., Bailey D.G. The effects of fruit juices on drug disposition: a new model for drug interactions. Eur J Clin Invest 2003, 33:10-16.
32. Hanley M.J., Cancalon P., Widmer W.W., Greenblatt D.J. The effect of grapefruit juice on drug disposition. Expert Opin Drug Metab Toxicol 2011, 7:267-286.
33. Seden K., Dickinson L., Khoo S., Back D. Grapefruit-drug interactions. Drugs 2010, 70:2373-2407.
34. Dolton M.J., Roufogalis B.D., McLachlan A.J. Fruit juices as perpetrators of drug interactions: the role of organic anion-transporting polypeptides. Clin Pharmacol Ther 2012, 92:622-630.
35. Srinivas N.R. Cranberry juice ingestion and clinical drug-drug interaction potentials; review of case studies and perspectives. J Pharm Pharm Sci 2013, 16:289-303.
36. Shader R.I. Foods, genetics, and drug interactions. J Clin Psychopharmacol 2003, 23:221-222.
37. Borrelli F., Capasso R., Izzo A.A. Garlic (Allium savitum L.): adverse effects and drug interactions in humans. Mol Nutr Food Res 2007, 51:1386-1397.
38. Unger M. Pharmacokinetic drug interactions involving Gingko biloba. Drug Metab Rev 2013, 56:353-385.
39. Abebe W. Herbal medication: potential for adverse interactions with analgesics drugs. J Clin Pharm Ther 2002, 27:391-401.
40. Boullata J. Natural health product interactions with medication. Nutr Clin Pract 2005, 20:33-51.
41. Rogovik A.L., Vohra S., Goldman R.D. Safety considerations and potential interactions of vitamins: should vitamins be considered drugs?. Ann Pharmacother 2010, 44:311-324.
42. Hussain S. Patient counseling about herbal-drug interactions. Hussain Afr J Tradit Complement Altern Med 2011, 8:152-163.
43. Nutescu E., Chuatrisorn I., Hellenbart E. Drug and dietary interactions of warfarin and novel oral anticoagulants: an update. J Thromb Thrombolysis 2011, 31:326-343.
44. Vieira MdLT, Huang S.M. Botanical-drug interactions: a scientific perspective. Planta Med 2012, 78:1400-1415.
45. Nowack R. Review article: cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St John's Wort-and beyond !. Nephrology 2008, 13:337-347.
46. Jauregui-Garrido B., Jauregui-Lobera I. Interactions between antiarythmic drugs and food. Nutr Hosp 2012, 27:1399-1407.
47. Darbar D., Dell'Orto S., Mörike K., Wilkinson G.R., Roden D.M. Dietary salt increases first-pass elimination of oral quinidine. Clin Pharmacol Ther 1997, 61:292-300.
48. Jauregui-Garrido B., Jauregui-Lobera I. Interactions between antihypertensive drugs and food. Nutr Hosp 2012, 27:1866-1875.
49. Holbrook A.M., Pereira J.A., Labiris R., McDonald H., Douketis J.D., Crowther M., et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 2005, 165:1095-1106.
50. Walenga J.M., Adiguzel C. Drug and diatery interactions of the new and emerging oral anticoagulants. Int J Clin Pract 2010, 64:956-967.
51. Nowack R., Andrassy J., Fischereder M., Unger M. Effects of dietary factors on drug transport and metabolism: the impact on dosage guidelines in transplant patients. Clin Pharmacol Ther 2009, 85:439-443.
52. Gonzales Canga A., Fernandez Martinez N., Sahagun Prieto A.M., Garcia Vieitez J.J., Diez Liebana M.J., Diez Laiz R., et al. Dietary fibers and its interaction with drugs. Nutr Hosp 2010, 25:535-539.
53. Mirtallo J.M. Complications associated with drug and nutrient interactions. J Infus Nurs 2004, 27:19-24.
54. Ohnishi N., Yokoyama T. Interactions between medicines and functional foods or dietary supplements. Keio J Med 2004, 53:137-150.
55. Aadil N., Houti I.E., Moussamih S. Drug intake during Ramadan. Br Med J 2004, 329:778-782.
56. Heuberger R. Polypharmacy and food-drug interactions among older persons: a review. J Nutr Gerontol Geriatr 2012, 31:325-403.
57. McCabe B.J. Prevention of food-drug interactions with special emphasis on older adults. Curr Opin Clin Nutr Metab Care 2004, 7:21-26.